FGFR1 inhibitor-2

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

FGFR1 inhibitor-2 

FGFR1 inhibitor-2 是一个 FGFR1 抑制剂（IC50 为 4.55 μM 在 MDA-MB-231细胞中）。FGFR1 inhibitor-2 可用于转移性三阴性乳腺癌的研究。

FGFR1 inhibitor-2

FGFR1 inhibitor-2 Chemical Structure

CAS No. : 2410612-08-5

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

FGFR1 inhibitor-2 is a FGFR1 inhibitor (IC50 is 4.55 μM in MDA-MB-231 cells). FGFR1 inhibitor-2 can be used for the research of metastatic triple-negative breast cancer[1].

IC50 & Target[1]

FGFR1

 

体外研究
(In Vitro)

FGFR1 inhibitor-2 (3 and 6 μM; 48 hours; MDA-MB-231) reduces the expression of FGFR1[1].
FGFR1 inhibitor-2 (0~5 μM; MDA-MB-231) increases the apoptotic index by 10.6-fold at 5 μM[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: MDA-MB-231
Concentration: 3 and 6 μM
Incubation Time: 48 hours
Result: Reduced the expression of FGFR1.

分子量

507.45

Formula

C25H22F5N3O3
CAS 号

2410612-08-5
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Ashraf-Uz-Zaman M, et al. Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer. Eur J Med Chem. 2021;209:112866.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务